Lawyers Run The World Feds Go After Golden Sunrise Nutraceuticals for Fake Covid19...

Feds Go After Golden Sunrise Nutraceuticals for Fake Covid19 Cure


- Advertisment -

The Federal Trade Commission (FTC) sued Golden Sunrise Nutraceutical for allegedly deceptively advertising its $23,000 COVID-19 treatment plan as “FDA accepted.”

Golden Sunrise Nutraceutical is a company based in Porterville, California. The company sells a variety of dietary supplements and claims that these products provide numerous health benefits including curing serious diseases.

The federal consumer protection watchdog also names Golden Sunrise Nutraceutical’s CEO Huu Tieu and Medical Director Stephen Meis as defendants in the case.

In the lawsuit, the FTC noted that the defendants are marketing their dietary supplements through four plans of care: 1) Primary Plan of Care; 2) Emergency D-Virus of Care; 3) Metabolic Plan of Care, 4) Cancer Plan of Care. They claimed that these treatment plans provide consumers with safe and effective treatment for serious diseases.

In March 2020, Golden Sunrise Nutraceutical started marketing its Emergency D-Virus plan as a treatment for COVID-19.

The FTC alleged that the defendants falsely claimed in its advertisements on billboards, websites, and social media that its herbal supplements ImunStem, Aktiffvate, and AnterFeerons are “uniquely qualified to treat and modify the course of the Coronavirus epidemic in CHINA and other countries.”

Additionally, the FTC alleged that the defendants falsely claimed that people who are frequently using one of the supplements included in the Emergency D-Virus treatment plan can expect “disappearance of viral symptoms within two to four days.”

Furthermore, the FTC alleged that the defendants are deceptively marketing their products as treatments for cancer, Parkinson’s disease, and many other serious illnesses.

In reality, the treatments are comprised mainly of different herbs and spices and the defendants’ health claims are unproven. Some of Golden Sunrise Nutraceutical’s treatment plans cost as much as $170,000 to $200,000, according to the Commission.

Moreover, the FTC alleged that the defendants falsely claimed that the Food and Drug Administration (FDA) reviewed and accepted its products and treatment plans.

In April 2020, the FTC sent a warning letter instructing the company to immediately remove all its false and misleading advertisements that its products can prevent, treat, or cure COVID-19. Despite the warning, the defendants continued deceptively advertising the Emergency D-Virus treatment plan as a “New Covid-19 Treatment.”

In a statement, FTC Bureau of Consumer Protection Director Andrew Smith said, “We warned the defendants not to falsely market their product as an effective treatment for COVID-19, but they didn’t stop. As this case makes clear, the FTC is prepared to sue companies that continue to make deceptive health claims about COVID-19 or other serious diseases.”

USA Herald
USA Herald
We are The People’s Media. USA Herald covers breaking news, politics, and investigative journalism. For anonymous tips please contact Support AT

What's your opinion?

Latest news

The MediaMath Debacle: Is This Ad Tech’s Theater of the Absurd?

In the tumultuous world of business, where the unexpected often becomes the norm, the recent acquisition of...

Are you Confused about ChatGPT and Marketing?

In the ever-evolving landscape of artificial intelligence (AI), myths and misconceptions abound like phantoms in the night....

AdTech’s Secret Sauce: It’s Not All About the Code

If you're anything like me, it's all too tempting to get caught up in the glitzy allure...

Fortnite: The Ultimate Playground for Brands and Gamers

There’s a war going on, and it’s not just between the players. It’s a war for attention,...

The US Ad Industry Dodged the Recession Bullet

The winds of change often blow in unpredictable directions in the world of advertising, and as the...

RethinkFirst Unveils Seasoned SaaS Marketing Executive to Chart a Vision for the Future of Behavioral Health

RethinkFirst, a global health technology company at the forefront of the behavioral health industry, has made a...

Must read

You might also likeRELATED
Recommended to you